Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
208.50    0.00 (0.00%)
Bid:
205.00
Ask:
212.00
Spread: 7.00 (3.415%)
Market Cap: £142.99m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Directorate Change

7 Jun 2024 07:00

RNS Number : 4982R
Helios Underwriting Plc
07 June 2024
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

 

Helios Underwriting plc

("Helios", "the Group" or "the Company")

 

Directorate Change

 

07 June 2024

 

Helios, the only publicly traded investment company offering instant access to a diverse portfolio at Lloyd's of London, the world's largest insurance market, today announces that Martin Reith has stepped down from his role as Chief Executive Officer, to pursue other opportunities. 

 

Michael Wade, currently Non-Executive Chairman, will become Executive Chairman with immediate effect as the search for Martin's successor begins. Nigel Hanbury, currently Executive Deputy Chairman, will become Non-Executive Deputy Chairman.

 

Helios recently reported a significant rise in profits and distributions in its full year 2024 results. The Company reported doubling of the capacity over the last two years of its Lloyd's syndicate portfolio to £507m for 2024, underlining its strategy and commitment as a manager of its spread on the 2024 year of account, where the Company has a retained proportion of 77%.The Company reiterated its intention to continue to act for third-party capital providers and anticipates this will grow as a proportion into 2025.

 

Following recent press speculation, the Board can confirm that it has explored the potential of establishing a new 'follow only' syndicate at Lloyd's, but it has decided not to pursue this concept in order to focus exclusively on supporting its spread portfolio.

 

Michael Wade, Executive Chairman of Helios, commented:

 

"Martin has made a significant contribution to Helios and has been instrumental in developing the Helios spread syndicate portfolio, accelerating the performance of the Company and growing our in-house management team. We wish him the very best for the future."

 

For further information, please contact:

 

Helios Underwriting plc

 

Michael Wade - Executive Chairman  Michael.Wade@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 

Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

 

Ed Berry / Tom O'Brien

+44 (0)7703 330 199 / +44 (0)7929 021 492

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £507m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZGGVGVNGDZZ
Date   Source Headline
16th Feb 20211:37 pmRNSRevision to Adjusted Net Asset Value
8th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting
28th Jun 20193:13 pmRNSResult of AGM
13th Jun 20197:00 amRNSChange of Adviser
13th Jun 20197:00 amRNSFundraising, Acquisition, Waiver & Notice of GM
31st May 20197:00 amRNSFinal results for the year ended 31 December 2018
30th May 20192:14 pmRNSDirector's Disclosure
17th May 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
10th May 20199:30 amRNSTrading Update
29th Mar 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20197:00 amRNSDirector Dealing
23rd Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.